HB 383 requires Tennessee's health commissioner to add alpha-gal syndrome - a rare meat allergy triggered by tick bites - to the state's official list of reportable diseases by July 1, 2025. Healthcare providers must then report diagnosed cases to the Department of Health under existing rules. This bill directly affects medical professionals who will need to submit these reports and public health officials who will track the condition. The law amends Tennessee Code Titles 4, 63, and 68 to implement this change, effective March 26, 2025.
SB 282, the "Individualized Investigational Treatment Act," creates a legal framework for patients with life-threatening or severely debilitating illnesses to access personalized medical treatments (like gene therapies or vaccines tailored to their genetic profile) when standard FDA-approved options have been exhausted. It directly affects eligible patients (who must meet specific criteria including physician attestation and written informed consent) and eligible facilities (those complying with federal human subjects protections). Key provisions require detailed written consent covering all treatment options, risks, and financial liability, while clarifying that insurers, health plans, and providers are **not obligated** to cover these treatments or related costs (TCA §§ 63-6-1304(a)-(d)). The law takes effect July 1, 2025, and explicitly states that heirs cannot be held liable for unpaid treatment debts if a patient dies during treatment (TCA § 63-6-1305).
This bill adds hepatitis C antibody (anti-HCV) testing to the standard blood screening required for all pregnant women in Tennessee during initial prenatal visits and between weeks 28-32 of pregnancy. If the anti-HCV test is reactive, labs must automatically conduct a follow-up HCV RNA test without requiring additional orders. It directly affects all pregnant women receiving routine prenatal care in Tennessee, expanding the required screening panel to include hepatitis C alongside existing tests for syphilis, rubella, and hepatitis B. The changes take effect July 1, 2025, and align hepatitis C testing protocols with existing disease reporting requirements for maternal health.
HB 229 extends the Board of Alcohol and Drug Abuse Counselors' authority until June 30, 2029, by amending Tennessee Code Sections 4-29-246 and 4-29-250. This change removes the board's previous expiration date, allowing it to continue overseeing licensing standards for alcohol and drug counselors. The board, established under Title 68, Chapter 24, will now operate without sunset provisions until the new date.
SB 44 adds doula services to TennCare, Tennessee's Medicaid program, making coverage available for certified doulas who provide continuous emotional and physical support during labor, birth, and postpartum care. It directly affects low-income pregnant people in Tennessee who may now access doula support through TennCare. The bill requires the Department of Health to establish a certification verification process for doulas who complete approved training programs meeting specific standards, including knowledge of anatomy, support strategies, and community resources. This process will verify doulas' qualifications before they can provide services covered under TennCare.
HB 404 extends the professional music therapy advisory committee under Tennessee's psychology board until June 30, 2027. This bill updates Tennessee Code Sections 4-29-246 and 4-29-248 to formally maintain the committee's existence, preventing its automatic termination. The committee, which advises the Board of Examiners in Psychology on music therapy licensure, is directly affected by this extension. The change ensures continuity for this advisory body without altering any substantive licensing rules.
SB 403 requires Tennessee healthcare facilities receiving public funds (like Medicaid reimbursements) to cover uncompensated care costs to cancel debt equal to that funding for eligible patients. Facilities must notify patients whose debt is canceled and cannot pursue legal action for the canceled amount. The bill also mandates annual reports from the Department of Health and TennCare on uncompensated care payments to the legislature. It directly affects hospitals receiving public funds for charity care and patients with outstanding medical debt.
SB 610 requires TennCare to cover continuous glucose monitors (CGMs) for eligible members with specific diabetes conditions. It directly affects TennCare enrollees diagnosed with Type 1 diabetes, gestational diabetes, or Type 2 diabetes meeting documented criteria like frequent low blood sugar episodes, high A1C levels, or hospitalizations related to diabetes complications. The bill mandates coverage only when prescribed by an endocrinologist or diabetes specialist confirming the member meets the eligibility requirements. The law takes effect January 1, 2026.
